English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 105 | Tables: 105 | Pharma & Healthcare
The global Transdermal Patch market size was US$ 7287 million in 2024 and is forecast to a readjusted size of US$ 9302 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
The global Transdermal Patch market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
By Type: (Dominant Segment vs High-Margin Innovation)
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Rx Channel
OTC Channel
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Hisamitsu Pharmaceutical in Europe)
- Emerging Product Trends: Methyl Salicylate-based Patch adoption vs. Rivastigmine Transdermal Patch premiumization
- Demand-Side Dynamics: Rx Channel growth in China vs. OTC Channel potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
Israel
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Transdermal Patch market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Rivastigmine Transdermal Patch in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., OTC Channel in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Methyl Salicylate-based Patch dominance in Europe vs. Rivastigmine Transdermal Patch demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Transdermal Patch Product Scope
1.2 Transdermal Patch by Type
1.2.1 Global Transdermal Patch Sales by Type (2020 & 2024 & 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch by Application
1.3.1 Global Transdermal Patch Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Patch Market Estimates and Forecasts (2020-2031)
1.4.1 Global Transdermal Patch Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Transdermal Patch Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Transdermal Patch Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Transdermal Patch Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Transdermal Patch Sales Market Share by Region (2020-2025)
2.2.2 Global Transdermal Patch Revenue Market Share by Region (2020-2025)
2.3 Global Transdermal Patch Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Transdermal Patch Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Transdermal Patch Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Transdermal Patch Market Size and Prospective (2020-2031)
2.4.2 Europe Transdermal Patch Market Size and Prospective (2020-2031)
2.4.3 China Transdermal Patch Market Size and Prospective (2020-2031)
2.4.4 Japan Transdermal Patch Market Size and Prospective (2020-2031)
2.4.5 India Transdermal Patch Market Size and Prospective (2020-2031)
2.4.6 Israel Transdermal Patch Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Transdermal Patch Historic Market Review by Type (2020-2025)
3.1.1 Global Transdermal Patch Sales by Type (2020-2025)
3.1.2 Global Transdermal Patch Revenue by Type (2020-2025)
3.1.3 Global Transdermal Patch Price by Type (2020-2025)
3.2 Global Transdermal Patch Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Transdermal Patch Sales Forecast by Type (2026-2031)
3.2.2 Global Transdermal Patch Revenue Forecast by Type (2026-2031)
3.2.3 Global Transdermal Patch Price Forecast by Type (2026-2031)
3.3 Different Types Transdermal Patch Representative Players
4 Global Market Size by Application
4.1 Global Transdermal Patch Historic Market Review by Application (2020-2025)
4.1.1 Global Transdermal Patch Sales by Application (2020-2025)
4.1.2 Global Transdermal Patch Revenue by Application (2020-2025)
4.1.3 Global Transdermal Patch Price by Application (2020-2025)
4.2 Global Transdermal Patch Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Transdermal Patch Sales Forecast by Application (2026-2031)
4.2.2 Global Transdermal Patch Revenue Forecast by Application (2026-2031)
4.2.3 Global Transdermal Patch Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Transdermal Patch Application
5 Competition Landscape by Players
5.1 Global Transdermal Patch Sales by Players (2020-2025)
5.2 Global Top Transdermal Patch Players by Revenue (2020-2025)
5.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2024)
5.4 Global Transdermal Patch Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Transdermal Patch, Product Type & Application
5.7 Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Transdermal Patch Sales by Company
6.1.1.1 North America Transdermal Patch Sales by Company (2020-2025)
6.1.1.2 North America Transdermal Patch Revenue by Company (2020-2025)
6.1.2 North America Transdermal Patch Sales Breakdown by Type (2020-2025)
6.1.3 North America Transdermal Patch Sales Breakdown by Application (2020-2025)
6.1.4 North America Transdermal Patch Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Transdermal Patch Sales by Company
6.2.1.1 Europe Transdermal Patch Sales by Company (2020-2025)
6.2.1.2 Europe Transdermal Patch Revenue by Company (2020-2025)
6.2.2 Europe Transdermal Patch Sales Breakdown by Type (2020-2025)
6.2.3 Europe Transdermal Patch Sales Breakdown by Application (2020-2025)
6.2.4 Europe Transdermal Patch Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Transdermal Patch Sales by Company
6.3.1.1 China Transdermal Patch Sales by Company (2020-2025)
6.3.1.2 China Transdermal Patch Revenue by Company (2020-2025)
6.3.2 China Transdermal Patch Sales Breakdown by Type (2020-2025)
6.3.3 China Transdermal Patch Sales Breakdown by Application (2020-2025)
6.3.4 China Transdermal Patch Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Transdermal Patch Sales by Company
6.4.1.1 Japan Transdermal Patch Sales by Company (2020-2025)
6.4.1.2 Japan Transdermal Patch Revenue by Company (2020-2025)
6.4.2 Japan Transdermal Patch Sales Breakdown by Type (2020-2025)
6.4.3 Japan Transdermal Patch Sales Breakdown by Application (2020-2025)
6.4.4 Japan Transdermal Patch Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Transdermal Patch Sales by Company
6.5.1.1 India Transdermal Patch Sales by Company (2020-2025)
6.5.1.2 India Transdermal Patch Revenue by Company (2020-2025)
6.5.2 India Transdermal Patch Sales Breakdown by Type (2020-2025)
6.5.3 India Transdermal Patch Sales Breakdown by Application (2020-2025)
6.5.4 India Transdermal Patch Major Customer
6.5.5 India Market Trend and Opportunities
6.6 Israel Market: Players, Segments, Downstream and Major Customers
6.6.1 Israel Transdermal Patch Sales by Company
6.6.1.1 Israel Transdermal Patch Sales by Company (2020-2025)
6.6.1.2 Israel Transdermal Patch Revenue by Company (2020-2025)
6.6.2 Israel Transdermal Patch Sales Breakdown by Type (2020-2025)
6.6.3 Israel Transdermal Patch Sales Breakdown by Application (2020-2025)
6.6.4 Israel Transdermal Patch Major Customer
6.6.5 Israel Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Hisamitsu Pharmaceutical
7.1.1 Hisamitsu Pharmaceutical Company Information
7.1.2 Hisamitsu Pharmaceutical Business Overview
7.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
7.1.5 Hisamitsu Pharmaceutical Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Information
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Johnson & Johnson Transdermal Patch Products Offered
7.2.5 Johnson & Johnson Recent Development
7.3 Novartis
7.3.1 Novartis Company Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Novartis Transdermal Patch Products Offered
7.3.5 Novartis Recent Development
7.4 UCB Pharma
7.4.1 UCB Pharma Company Information
7.4.2 UCB Pharma Business Overview
7.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.4.4 UCB Pharma Transdermal Patch Products Offered
7.4.5 UCB Pharma Recent Development
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Business Overview
7.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Mylan Transdermal Patch Products Offered
7.5.5 Mylan Recent Development
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Company Information
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
7.6.5 Teva Pharmaceutical Recent Development
7.7 Nitto Denko
7.7.1 Nitto Denko Company Information
7.7.2 Nitto Denko Business Overview
7.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Nitto Denko Transdermal Patch Products Offered
7.7.5 Nitto Denko Recent Development
7.8 Grünenthal
7.8.1 Grünenthal Company Information
7.8.2 Grünenthal Business Overview
7.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Grünenthal Transdermal Patch Products Offered
7.8.5 Grünenthal Recent Development
7.9 IBSA Group
7.9.1 IBSA Group Company Information
7.9.2 IBSA Group Business Overview
7.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.9.4 IBSA Group Transdermal Patch Products Offered
7.9.5 IBSA Group Recent Development
7.10 GSK
7.10.1 GSK Company Information
7.10.2 GSK Business Overview
7.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.10.4 GSK Transdermal Patch Products Offered
7.10.5 GSK Recent Development
7.11 Luye Pharma Group
7.11.1 Luye Pharma Group Company Information
7.11.2 Luye Pharma Group Business Overview
7.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Luye Pharma Group Transdermal Patch Products Offered
7.11.5 Luye Pharma Group Recent Development
7.12 Pfizer
7.12.1 Pfizer Company Information
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Pfizer Transdermal Patch Products Offered
7.12.5 Pfizer Recent Development
7.13 Chattem
7.13.1 Chattem Company Information
7.13.2 Chattem Business Overview
7.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Chattem Transdermal Patch Products Offered
7.13.5 Chattem Recent Development
7.14 Dr Reddy’s Laboratories
7.14.1 Dr Reddy’s Laboratories Company Information
7.14.2 Dr Reddy’s Laboratories Business Overview
7.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered
7.14.5 Dr Reddy’s Laboratories Recent Development
7.15 Bayer
7.15.1 Bayer Company Information
7.15.2 Bayer Business Overview
7.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Bayer Transdermal Patch Products Offered
7.15.5 Bayer Recent Development
7.16 Mundipharma
7.16.1 Mundipharma Company Information
7.16.2 Mundipharma Business Overview
7.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Mundipharma Transdermal Patch Products Offered
7.16.5 Mundipharma Recent Development
7.17 Endo International
7.17.1 Endo International Company Information
7.17.2 Endo International Business Overview
7.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Endo International Transdermal Patch Products Offered
7.17.5 Endo International Recent Development
7.18 Beijing Tide Pharmaceutical
7.18.1 Beijing Tide Pharmaceutical Company Information
7.18.2 Beijing Tide Pharmaceutical Business Overview
7.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
7.18.5 Beijing Tide Pharmaceutical Recent Development
8 Transdermal Patch Manufacturing Cost Analysis
8.1 Transdermal Patch Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Transdermal Patch
8.4 Transdermal Patch Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Transdermal Patch Distributors List
9.3 Transdermal Patch Customers
10 Transdermal Patch Market Dynamics
10.1 Transdermal Patch Industry Trends
10.2 Transdermal Patch Market Drivers
10.3 Transdermal Patch Market Challenges
10.4 Transdermal Patch Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Transdermal Patch Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Transdermal Patch Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Transdermal Patch Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Transdermal Patch Sales (M Pcs) by Region (2020-2025)
Table 5. Global Transdermal Patch Sales Market Share by Region (2020-2025)
Table 6. Global Transdermal Patch Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Transdermal Patch Revenue Share by Region (2020-2025)
Table 8. Global Transdermal Patch Sales (M Pcs) Forecast by Region (2026-2031)
Table 9. Global Transdermal Patch Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Transdermal Patch Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Transdermal Patch Revenue Share Forecast by Region (2026-2031)
Table 12. Global Transdermal Patch Sales by Type (M Pcs) & (2020-2025)
Table 13. Global Transdermal Patch Sales Share by Type (2020-2025)
Table 14. Global Transdermal Patch Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Transdermal Patch Price by Type (USD/Pc) & (2020-2025)
Table 16. Global Transdermal Patch Sales by Type (M Pcs) & (2026-2031)
Table 17. Global Transdermal Patch Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Transdermal Patch Price by Type (USD/Pc) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Transdermal Patch Sales by Application (M Pcs) & (2020-2025)
Table 21. Global Transdermal Patch Sales Share by Application (2020-2025)
Table 22. Global Transdermal Patch Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Transdermal Patch Price by Application (USD/Pc) & (2020-2025)
Table 24. Global Transdermal Patch Sales by Application (M Pcs) & (2026-2031)
Table 25. Global Transdermal Patch Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Transdermal Patch Price by Application (USD/Pc) & (2026-2031)
Table 27. New Sources of Growth in Transdermal Patch Application
Table 28. Global Transdermal Patch Sales by Company (M Pcs) & (2020-2025)
Table 29. Global Transdermal Patch Sales Share by Company (2020-2025)
Table 30. Global Transdermal Patch Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Transdermal Patch Revenue Share by Company (2020-2025)
Table 32. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2024)
Table 33. Global Market Transdermal Patch Average Price by Company (USD/Pc) & (2020-2025)
Table 34. Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Transdermal Patch, Product Type & Application
Table 36. Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 39. North America Transdermal Patch Sales Market Share by Company (2020-2025)
Table 40. North America Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 42. North America Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 43. North America Transdermal Patch Sales Market Share by Type (2020-2025)
Table 44. North America Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 45. North America Transdermal Patch Sales Market Share by Application (2020-2025)
Table 46. Europe Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 47. Europe Transdermal Patch Sales Market Share by Company (2020-2025)
Table 48. Europe Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 50. Europe Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 51. Europe Transdermal Patch Sales Market Share by Type (2020-2025)
Table 52. Europe Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 53. Europe Transdermal Patch Sales Market Share by Application (2020-2025)
Table 54. China Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 55. China Transdermal Patch Sales Market Share by Company (2020-2025)
Table 56. China Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 58. China Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 59. China Transdermal Patch Sales Market Share by Type (2020-2025)
Table 60. China Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 61. China Transdermal Patch Sales Market Share by Application (2020-2025)
Table 62. Japan Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 63. Japan Transdermal Patch Sales Market Share by Company (2020-2025)
Table 64. Japan Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 66. Japan Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 67. Japan Transdermal Patch Sales Market Share by Type (2020-2025)
Table 68. Japan Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 69. Japan Transdermal Patch Sales Market Share by Application (2020-2025)
Table 70. India Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 71. India Transdermal Patch Sales Market Share by Company (2020-2025)
Table 72. India Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 74. India Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 75. India Transdermal Patch Sales Market Share by Type (2020-2025)
Table 76. India Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 77. India Transdermal Patch Sales Market Share by Application (2020-2025)
Table 78. Israel Transdermal Patch Sales by Company (2020-2025) & (M Pcs)
Table 79. Israel Transdermal Patch Sales Market Share by Company (2020-2025)
Table 80. Israel Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)
Table 81. Israel Transdermal Patch Revenue Market Share by Company (2020-2025)
Table 82. Israel Transdermal Patch Sales by Type (2020-2025) & (M Pcs)
Table 83. Israel Transdermal Patch Sales Market Share by Type (2020-2025)
Table 84. Israel Transdermal Patch Sales by Application (2020-2025) & (M Pcs)
Table 85. Israel Transdermal Patch Sales Market Share by Application (2020-2025)
Table 86. Hisamitsu Pharmaceutical Company Information
Table 87. Hisamitsu Pharmaceutical Description and Business Overview
Table 88. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 89. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 90. Hisamitsu Pharmaceutical Recent Development
Table 91. Johnson & Johnson Company Information
Table 92. Johnson & Johnson Description and Business Overview
Table 93. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 94. Johnson & Johnson Transdermal Patch Product
Table 95. Johnson & Johnson Recent Development
Table 96. Novartis Company Information
Table 97. Novartis Description and Business Overview
Table 98. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 99. Novartis Transdermal Patch Product
Table 100. Novartis Recent Development
Table 101. UCB Pharma Company Information
Table 102. UCB Pharma Description and Business Overview
Table 103. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 104. UCB Pharma Transdermal Patch Product
Table 105. UCB Pharma Recent Development
Table 106. Mylan Company Information
Table 107. Mylan Description and Business Overview
Table 108. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 109. Mylan Transdermal Patch Product
Table 110. Mylan Recent Development
Table 111. Teva Pharmaceutical Company Information
Table 112. Teva Pharmaceutical Description and Business Overview
Table 113. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 114. Teva Pharmaceutical Transdermal Patch Product
Table 115. Teva Pharmaceutical Recent Development
Table 116. Nitto Denko Company Information
Table 117. Nitto Denko Description and Business Overview
Table 118. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 119. Nitto Denko Transdermal Patch Product
Table 120. Nitto Denko Recent Development
Table 121. Grünenthal Company Information
Table 122. Grünenthal Description and Business Overview
Table 123. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 124. Grünenthal Transdermal Patch Product
Table 125. Grünenthal Recent Development
Table 126. IBSA Group Company Information
Table 127. IBSA Group Description and Business Overview
Table 128. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 129. IBSA Group Transdermal Patch Product
Table 130. IBSA Group Recent Development
Table 131. GSK Company Information
Table 132. GSK Description and Business Overview
Table 133. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 134. GSK Transdermal Patch Product
Table 135. GSK Recent Development
Table 136. Luye Pharma Group Company Information
Table 137. Luye Pharma Group Description and Business Overview
Table 138. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 139. Luye Pharma Group Transdermal Patch Product
Table 140. Luye Pharma Group Recent Development
Table 141. Pfizer Company Information
Table 142. Pfizer Description and Business Overview
Table 143. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 144. Pfizer Transdermal Patch Product
Table 145. Pfizer Recent Development
Table 146. Chattem Company Information
Table 147. Chattem Description and Business Overview
Table 148. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 149. Chattem Transdermal Patch Product
Table 150. Chattem Recent Development
Table 151. Dr Reddy’s Laboratories Company Information
Table 152. Dr Reddy’s Laboratories Description and Business Overview
Table 153. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 154. Dr Reddy’s Laboratories Transdermal Patch Product
Table 155. Dr Reddy’s Laboratories Recent Development
Table 156. Bayer Company Information
Table 157. Bayer Description and Business Overview
Table 158. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 159. Bayer Transdermal Patch Product
Table 160. Bayer Recent Development
Table 161. Mundipharma Company Information
Table 162. Mundipharma Description and Business Overview
Table 163. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 164. Mundipharma Transdermal Patch Product
Table 165. Mundipharma Recent Development
Table 166. Endo International Company Information
Table 167. Endo International Description and Business Overview
Table 168. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 169. Endo International Transdermal Patch Product
Table 170. Endo International Recent Development
Table 171. Beijing Tide Pharmaceutical Company Information
Table 172. Beijing Tide Pharmaceutical Description and Business Overview
Table 173. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2020-2025)
Table 174. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 175. Beijing Tide Pharmaceutical Recent Development
Table 176. Production Base and Market Concentration Rate of Raw Material
Table 177. Key Suppliers of Raw Materials
Table 178. Transdermal Patch Distributors List
Table 179. Transdermal Patch Customers List
Table 180. Transdermal Patch Market Trends
Table 181. Transdermal Patch Market Drivers
Table 182. Transdermal Patch Market Challenges
Table 183. Transdermal Patch Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Patch Product Picture
Figure 2. Global Transdermal Patch Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Transdermal Patch Sales Market Share by Type in 2024 & 2031
Figure 4. Methyl Salicylate-based Patch Product Picture
Figure 5. Rivastigmine Transdermal Patch Product Picture
Figure 6. Fentanyl Transdermal Patch Product Picture
Figure 7. Lidocaine Patch Product Picture
Figure 8. Diclofenac Patch Product Picture
Figure 9. Nicotine Transdermal Patch Product Picture
Figure 10. Others Product Picture
Figure 11. Global Transdermal Patch Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 12. Global Transdermal Patch Sales Market Share by Application in 2024 & 2031
Figure 13. Rx Channel Examples
Figure 14. OTC Channel Examples
Figure 15. Global Transdermal Patch Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Transdermal Patch Sales Growth Rate (2020-2031) & (US$ Million)
Figure 17. Global Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 18. Global Transdermal Patch Price Trends Growth Rate (2020-2031) & (USD/Pc)
Figure 19. Transdermal Patch Report Years Considered
Figure 20. Global Market Transdermal Patch Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 21. Global Transdermal Patch Revenue Market Share by Region: 2020 VS 2024
Figure 22. North America Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. North America Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 24. Europe Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 26. China Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. China Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 28. Japan Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. Japan Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 30. India Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)
Figure 31. India Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 32. Israel Transdermal Patch Revenue (US$ Million) Growth Rate (2020-2031)
Figure 33. Israel Transdermal Patch Sales (M Pcs) Growth Rate (2020-2031)
Figure 34. Global Transdermal Patch Revenue Share by Type (2020-2025)
Figure 35. Global Transdermal Patch Sales Share by Type (2026-2031)
Figure 36. Global Transdermal Patch Revenue Share by Type (2026-2031)
Figure 37. Global Transdermal Patch Revenue Share by Application (2020-2025)
Figure 38. Global Transdermal Patch Revenue Growth Rate by Application in 2020 & 2024
Figure 39. Global Transdermal Patch Sales Share by Application (2026-2031)
Figure 40. Global Transdermal Patch Revenue Share by Application (2026-2031)
Figure 41. Global Transdermal Patch Sales Share by Company (2024)
Figure 42. Global Transdermal Patch Revenue Share by Company (2024)
Figure 43. Global 5 Largest Transdermal Patch Players Market Share by Revenue in Transdermal Patch: 2020 & 2024
Figure 44. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 45. Manufacturing Cost Structure of Transdermal Patch
Figure 46. Manufacturing Process Analysis of Transdermal Patch
Figure 47. Transdermal Patch Industrial Chain
Figure 48. Channels of Distribution (Direct Vs Distribution)
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
